Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers.
Social media users take note: You won't be able to snap that fall foliage selfie at a popular Vermont spot. The town has temporarily closed the road to nonresidents due to overcrowding and “poorly behaved tourists.”
